Correlation Between Synchrony Financial and Faron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Synchrony Financial and Faron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synchrony Financial and Faron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synchrony Financial and Faron Pharmaceuticals Oy, you can compare the effects of market volatilities on Synchrony Financial and Faron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synchrony Financial with a short position of Faron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synchrony Financial and Faron Pharmaceuticals.

Diversification Opportunities for Synchrony Financial and Faron Pharmaceuticals

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Synchrony and Faron is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Synchrony Financial and Faron Pharmaceuticals Oy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Faron Pharmaceuticals and Synchrony Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synchrony Financial are associated (or correlated) with Faron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Faron Pharmaceuticals has no effect on the direction of Synchrony Financial i.e., Synchrony Financial and Faron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Synchrony Financial and Faron Pharmaceuticals

Assuming the 90 days trading horizon Synchrony Financial is expected to generate 0.77 times more return on investment than Faron Pharmaceuticals. However, Synchrony Financial is 1.3 times less risky than Faron Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Faron Pharmaceuticals Oy is currently generating about -0.37 per unit of risk. If you would invest  6,773  in Synchrony Financial on November 7, 2024 and sell it today you would earn a total of  146.00  from holding Synchrony Financial or generate 2.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy90.48%
ValuesDaily Returns

Synchrony Financial  vs.  Faron Pharmaceuticals Oy

 Performance 
       Timeline  
Synchrony Financial 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Synchrony Financial are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Synchrony Financial is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Faron Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Faron Pharmaceuticals Oy are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Faron Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Synchrony Financial and Faron Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Synchrony Financial and Faron Pharmaceuticals

The main advantage of trading using opposite Synchrony Financial and Faron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synchrony Financial position performs unexpectedly, Faron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Faron Pharmaceuticals will offset losses from the drop in Faron Pharmaceuticals' long position.
The idea behind Synchrony Financial and Faron Pharmaceuticals Oy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges